Generics Makers to Take Part in TABD.
WASHINGTON--In a move that is expected to give generic drug manufacturers greater influence in shaping international trade policy governing pharmaceutical products the chief executive officers of five leading U.S. generics companies have been invited to participate in a major trade conference to be held in Berlin next month.
The invitation to take part in the Transatlantic Business Dialogue (TABD) comes as the result of a three-year campaign engineered by the Generic Pharmaceutical Industry Association (GPIA) on behalf of its members. The participation of the suppliers is expected to facilitate additional global marketing opportunities for GPIA members.
"We look forward to this unique chance to closely collaborate with our colleagues from the innovator community to promote expanded opportunities in overseas markets for the American drug industry," comments Alice Till, president of GPIA.
The chief executive officers invited to attend the TABD are Ivax Corp.'s Philip Frost, Schein Pharmaceuticals' Martin Sperber, Sicor Inc.'s Carlo Salvi, Barr Laboratories' Bruce Downey and Mylan Laboratories' Milan Puskar.
In extending the invitation, a TABD representative called on the executives to "help create new solutions to remaining transatlantic as well as global trade barriers."
|Printer friendly Cite/link Email Feedback|
|Comment:||Generics Makers to Take Part in TABD.|
|Publication:||Chain Drug Review|
|Date:||Sep 27, 1999|
|Previous Article:||Generics Makers Face Opportunities, Challenges.|
|Next Article:||Zenith Goldline Markets Balanced Generics Line.|